NM_001010898.4:c.2036A>G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001010898.4(SLC6A17):​c.2036A>G​(p.Lys679Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0039 in 1,614,160 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0057 ( 7 hom., cov: 33)
Exomes 𝑓: 0.0037 ( 44 hom. )

Consequence

SLC6A17
NM_001010898.4 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.75

Publications

7 publications found
Variant links:
Genes affected
SLC6A17 (HGNC:31399): (solute carrier family 6 member 17) The protein encoded by this gene is a member of the SLC6 family of transporters, which are responsible for the presynaptic uptake of most neurotransmitters. The encoded vesicular transporter is selective for proline, glycine, leucine and alanine. In mouse, the strongest expression of this gene was in cortical and hippocampal tissues where expression increased during embryonic brain development and peaked postnatally. Defects in this gene cause a form of autosomal recessive intellectual disability. [provided by RefSeq, Jul 2017]
SLC6A17 Gene-Disease associations (from GenCC):
  • progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Illumina, Orphanet, Labcorp Genetics (formerly Invitae)
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035065114).
BP6
Variant 1-110198296-A-G is Benign according to our data. Variant chr1-110198296-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376873.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 7 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A17NM_001010898.4 linkc.2036A>G p.Lys679Arg missense_variant Exon 12 of 12 ENST00000331565.5 NP_001010898.1 Q9H1V8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A17ENST00000331565.5 linkc.2036A>G p.Lys679Arg missense_variant Exon 12 of 12 2 NM_001010898.4 ENSP00000330199.3 Q9H1V8

Frequencies

GnomAD3 genomes
AF:
0.00573
AC:
872
AN:
152156
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0373
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00610
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00561
AC:
1410
AN:
251398
AF XY:
0.00553
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0333
Gnomad NFE exome
AF:
0.00508
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00371
AC:
5419
AN:
1461886
Hom.:
44
Cov.:
33
AF XY:
0.00381
AC XY:
2772
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33480
American (AMR)
AF:
0.00195
AC:
87
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00161
AC:
42
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.0297
AC:
1585
AN:
53412
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00320
AC:
3553
AN:
1112012
Other (OTH)
AF:
0.00232
AC:
140
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
366
732
1097
1463
1829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00573
AC:
872
AN:
152274
Hom.:
7
Cov.:
33
AF XY:
0.00685
AC XY:
510
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41562
American (AMR)
AF:
0.00157
AC:
24
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.0373
AC:
396
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00610
AC:
415
AN:
68000
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00460
Hom.:
8
Bravo
AF:
0.00253
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00488
AC:
42
ExAC
AF:
0.00534
AC:
648
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00338
EpiControl
AF:
0.00255

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A17: PP2, BS2 -

Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.020
T
Eigen
Benign
-0.079
Eigen_PC
Benign
0.054
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.86
D
MetaRNN
Benign
0.0035
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
4.8
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.14
Sift
Uncertain
0.025
D
Sift4G
Benign
0.14
T
Polyphen
0.0090
B
Vest4
0.14
MVP
0.72
MPC
0.47
ClinPred
0.014
T
GERP RS
4.4
Varity_R
0.15
gMVP
0.51
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41313405; hg19: chr1-110740918; API